Short interest in Cencora Inc (NYSE:COR) decreased during the last reporting period, falling from 6.73M to 6.63M. This put 5.89% of the company's publicly available shares short. Short interest in ...

Shares of Cencora (COR) have been strong performers lately, with the stock up 11.2% over the past month. The stock hit a new 52-week high of $309.35 in the previous session. Cencora has gained 35. ...

James Cleary; Chief Financial Officer, Executive Vice President; Cencora Inc Hello, everyone, and thank you for joining the Cencora fiscal 2025 second-quarter results conference call. My name is Lucy, ...

Hello, everyone, and thank you for joining the Cencora Fiscal 2025 Second Quarter Results Conference Call. My name is Lucy, and I will be coordinating your call today. [Operator Instructions] I ...

Cencora, Inc. COR reported second-quarter ... International Healthcare Solutions This segment includes Alliance Healthcare, World Courier, Innomar and Profarma Specialty. Revenues amounted ...

Cencora delivered a strong quarter with notable growth in the U.S. Healthcare Solutions segment, driven by specialty products and strategic investments. The company raised its full-year EPS ...

We recently published a list of Jim Cramer Rediscovers Love For Magnificent 7 & Discusses These 11 Stocks In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands ...

May 7 (Reuters) - U.S. drug distributor Cencora (COR.N), opens new tab raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.

CONSHOHOCKEN, Pa. (AP) — CONSHOHOCKEN, Pa. (AP) — Cencora, Inc. (COR) on Wednesday reported fiscal second-quarter profit of $717.9 million. On a per-share basis, the Conshohocken, Pennsylvania ...